The effect of some flavone drugs on the conversion of prostacyclin to 6-oxoprostaglandin E1

This publication has 20 references indexed in Scilit:

• In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin
  Biochemical Pharmacology, 1983
• Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolism
  Life Sciences, 1982
• Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin
  Biochemical Pharmacology, 1982
• Release of biologically active substances from non-aggregating human platelets
  European Journal of Pharmacology, 1982
• A radioimmunoassay for 6-ketoprostaglandin E1
  Prostaglandins, Leukotrienes and Medicine, 1982
• 6-Keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent
  Prostaglandins, 1980
• Hepatic metabolism of prostacyclin (PGI2) in the rabbit: Formation of a potent novel inhibitor of platelet aggregation
  Biochemical and Biophysical Research Communications, 1980
• Hemmung der Prostaglandinsynthetase durch Flavonoide und Phenolderivate im Vergleich mit deren O₂^−•‐Radikalfänger‐eigenschaften
  Archiv der Pharmazie, 1980
• Hypotensive and renovascular actions of 6-keto-prostaglandin E1, a metabolite of prostacyclin
  European Journal of Pharmacology, 1979
• Inhibition of renal PGE2-9-ketoreductase by diuretics
  Prostaglandins, 1976